AFELIMOMAB
UNII 6SC756X51V

Substance Identification & Data

This profile provides standardized clinical and technical data for Afelimomab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6SC756X51V.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 156227-98-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

6SC756X51V

CAS Registry Number

156227-98-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

AFELIMOMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C166960

National Cancer Institute reference terminology for clinical and research data.

INN ID

7340

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Afelimomab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

AFELIMOMAB

Common Names & Synonyms

AFELIMOMAB [INN]

AFELIMOMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G3, ANTI-(HUMAN TUMOR NECROSIS FACTOR .ALPHA.) F(AB')2 FRAGMENT (MOUSE MONOCLONAL LU54107 .GAMMA.3-CHAIN), DISULFIDE WITH MOUSE MONOCLONAL LU54107 .KAPPA.-CHAIN, DIMER

SYS